Sab Biotherapeutics, Inc. · NASDAQ:SABS

Woodline Partners LP reported a 9.90% stake in Sab Biotherapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Woodline Partners LP reported a 9.90% stake in Sab Biotherapeutics, Inc., 7,125,881 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
9.90%
Shares
7,125,881
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Woodline Partners LP9.90%7,125,881

Source

View original at SEC

Related